Table 1.
Demographic and clinical characteristics (n = 31).
| Sex, female/male, (n) | 9/22 |
| Age, (y), mean (SD) | 59.7 (±8.1) |
| Body mass index, mean (SD) | 27 (±4.7) |
| Cerebral infarction/cerebral haemorrhage/cerebellar haemorrhage (n) | 18/10/3 |
| Right/left/bilateral lesion (n) | 15/15/1 |
| Time since stroke (y) | 8.5 (±0.9) |
| Cardiovascular disease/pulmonary disease/diabetes/musculoskeletal pain/depression (n) | 20/3/7/16/11 |
| Smoking (n) | 6 |
| Beta blocker/calcium channel blocker/ACE inhibitor/angiotensin antagonist/alpha blocker/diuretics (n) | 15/9/6/4/2/5 |
| FMA, median (IQR) | 29 (22–34) |
| Walking aid, (n) | 14a |
| Ankle-foot orthosis (n) | 7 |
| Wheelchair (n) | 4b |
SD: standard deviation: FMA: Fugl-Meyer Assessment. Motor score lower extremity, maximum 34. IQR: interquartile range: aoccasional use in four subjects: boccasional use.